logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CHINA STARCH (03838) spent 34,600 Hong Kong dollars to repurchase 200,000 shares on March 25th.

date
17:52 25/03/2026
avatar
GMT Eight
China Starch (03838) announced that it will spend 34,600 Hong Kong dollars to repurchase 200,000 shares on March 25, 2026.
CHINA STARCH (03838) issued an announcement to repurchase 200,000 shares at a cost of HK$34,600 on March 25, 2026.
Related Articles
HK Stock
Chuan Holding (01420) announces a profit surge. It is expected that the shareholders' net profit will increase significantly by approximately 132.9% in 2025.
HK Stock
NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.
China Stock
China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
Chuan Holding (01420) announces a profit surge. It is expected that the shareholders' net profit will increase significantly by approximately 132.9% in 2025.
HK Stock
NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.
HK Stock
China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
China Stock
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
icon
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
icon
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
icon
24/03/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.